The only infusion set indicated for up to 7 days of wear


The Medtronic Extended™ infusion set and Extended™ reservoir designed for life with fewer interruptions


Shop online

One set change per week
compared to every 2 to 3 days1


The first and only infusion set and reservoir to be designed for longer wear, without compromising comfort1 or insulin delivery.2

5 changes per month versus 10 changes per month with another pump system or infusion set.
calendar comparing monthly usage

Advancing insulin delivery in pump therapy

MiniMed™ 780G system


Use the Medtronic Extended™ infusion set and Extended™ reservoir with the MiniMed™ 780G system and other Medtronic insulin pumps.

The MiniMed™ 780G system is the only system with Meal Detection™ technology† that provides automatic adjustments and corrections to sugar levels every 5 minutes.‡ Learn more about the MiniMed™ 780G system.


Request info

MiniMed™ 780G system with SmartGuard™ technology

Smart devices sold separatelyΦ

Designed with new materials to allow a longer wear*


+ + + + + Medtronic Extended™ infusion sets components
+ New infusion set capability
The difference

The difference


Our Diabetes Clinical Educator, Paola, explains what’s new about the Medtronic Extended™ infusion set.

The difference

Effect on site


Our Diabetes Clinical Educator, Primilee, explains the effect of insulin is infused at the site for 7 days using the Extended™ infusion set.

The difference

Extended™ reservoir


Our Diabetes Clinical Educator, Primilee, explains how the Extended™ reservoir holds the same amount of insulin as the standard reservoir, but can be worn longer.

Ready, Extended™ Infusion Set, Go!


Being able to wear an infusion set for up to 7 days really helps with my freedom. It lets me go out to do the things that I love and not have to worry about carrying all the supplies that I used to."

- Jaylen, Medtronic Ambassador

Ambassadors receive promotional items and educational material to use and share as they see fit. Opinions are based on the Ambassador's actual experience; individual results may vary.

Jaylen's story
Man wearing Extended™ infusion set

Simple to use and virtually painless5


With the all-in-one serter, set changes are quick and easy to do. Watch how to insert the Extended™ infusion set and reservoir.


Remove tape

1. Remove tape

Squeeze and remove safety cap

2. Squeeze and remove safety cap

Place Serter on body

3. Place serter on body

Press the button

4. Press the button


To get the first and only infusion set designed for twice the wear, order online or by calling 1-800-646-4633 and select option 2. (Monday - Friday, 8:00 a.m. to 6:00 p.m. CT). Please note that the Extended™ infusion set requires a new prescription.

Discover the MiniMed™ 780G system the Medtronic Extended™ infusion set and reservoir designed for up to 7 days of wear.

Complete the form to learn more.


The MiniMed 780G insulin pump system


How can we communicate with you?

I have read and understood the terms of this marketing authorization. I authorize Medtronic to use my protected health information for the purposes described in the authorization.

HIPAA MARKETING AUTHORIZATION FOR USE OF PROTECTED HEALTH INFORMATION

Medtronic Diabetes* respects the privacy of all our customers. With your permission, we may use your protected health information, including your contact information and health-related data, for marketing purposes, promotional offers, survey opportunities, and advertising that we think may be of interest to you. We may also share your information with Medtronic Diabetes representatives and contractors.  

Please note that this Authorization is optional, and you may refuse to opt in.  If you do not want to opt in, it will not affect your treatment, health insurance eligibility, or benefits, and you will not be stopped or prevented from accessing the CareLink™ Personal system, or other Medtronic Diabetes products, mobile apps, or services. You will be provided with a copy of this Authorization after it is acknowledged.

This Authorization will expire four (4) years from the date you submit this authorization online but may expire sooner if required by applicable law, or if you remove it by following one of the methods below:

  1. E-mail takecontrol@medtronic.com
  2. Sign in to the Profile page and update your communication preferences at www.Diabetes.shop/communication
  3. Contact Customer Service Center at 800-646-4633

Opting out will not affect actions Medtronic Diabetes has already taken based on this Authorization. Information disclosed pursuant to this Authorization may be re-disclosed by the recipient of the information and may no longer be protected by federal privacy standards. If you have additional questions about this Authorization, please contact our Customer Service Center at 800-646-4633 or by email at takecontrol@medtronic.com.

Please review our Notice of Privacy Practices and Privacy Statement or contact our support team to get details on how Medtronic Diabetes processes your personal data, the involvement of affiliates and third-party data processors, cross-border transfer, and your rights as a data subject.

*MiniMed Distribution Corp. and Medtronic MiniMed, Inc. are “Medtronic Diabetes”

 

I agree to receive phone calls and/or artificial prerecorded marketing voice messages sent from or on behalf of Medtronic Diabetes using automated technology at the phone number(s) I have provided.

CONSENT FOR RECEIPT OF PHONE COMMUNICATIONS

You consent to receiving phone calls, including pre-recorded and auto-dialed communications, at the phone number(s) submitted above using automated technology from or on behalf of MiniMed Distribution Corp. and its business associate Medtronic MiniMed, Inc. (collectively “Medtronic Diabetes”), concerning the marketing, advertising and/or offers of sale of Medtronic Diabetes products, therapies and services. You also certify that you are (a) age 18 and older and (b) authorizing and consenting to use of the information provided for Medtronic Diabetes to contact you. Your consent is not a condition for purchase. Airtime, message and data rates may apply. You may opt out at any time by (i) e-mailing takecontrol@medtronic.com; or (ii) signing into your myHome profile and updating your communication preferences (www.diabetes.shop/communication).

I agree to receive marketing SMS text communications using automated technology sent from or on behalf of Medtronic Diabetes at the mobile phone number(s) I have provided (message frequency may vary).

CONSENT FOR RECEIPT OF TEXT COMMUNICATIONS

You consent to receiving text messages at the phone number(s) submitted above using automated technology from or on behalf of MiniMed Distribution Corp. and its business associate Medtronic MiniMed, Inc. (collectively “Medtronic Diabetes”), concerning the marketing, advertising and/or offers of sale of Medtronic Diabetes products, therapies and services. You also certify that you are (a) age 18 and older and (b) authorizing and consenting to use of the information provided for Medtronic Diabetes to contact you. Your consent is not a condition for purchase. Airtime, message and data rates may apply. You may opt out at any time by (i) texting "STOP" in return to a text; (ii) sending an email to takecontrol@medtronic.com; or (iii) signing into your myHome profile and updating your communication preferences (www.diabetes.shop/communication).



Frequently asked questions


Only the Extended™ reservoir is tested and cleared to keep insulin stable and safe to use for up to 7 days.
If you’re using a MiniMed™ 780G, MiniMed™ 770G, MiniMed™ 670G, or MiniMed™ 630G insulin pump, you can order and use the Medtronic Extended™ infusion set. Extended™ products are not compatible with MiniMed™ Paradigm systems.
Yes, a new prescription is required for the Medtronic Extended™ infusion set and Extended™ reservoir products. If you’re interested, we can request a prescription from your healthcare team on your behalf.
No, each Medtronic Extended™ infusion set has a built-in serter.
The Medtronic Extended™ infusion set is cleared for use on the abdomen, back of the arm, lower back, buttocks, and thighs. We recommend referring to the product instructions while inserting this set.
We offer a 23" or 32" with either a 6 mm or 9 mm cannula.
No, the Extended™ reservoir is only indicated for use with the Medtronic Extended™ infusion set. Use for a maximum of 7 days, or according to the insulin labeling, whichever duration is shorter. For more details, visit this important safety information.

No, other Medtronic infusion sets are only cleared for 2-3 days. The Extended™ infusion set has new technology and different materials that allow it to be worn for twice the wear time.

The Medtronic Extended™ infusion set is designed with new materials to allow for longer wear (up to 7 days). Three updates have been made to the materials in the tubing connector, the tubing itself, and the adhesive patch.
Although the insertion is the same as Mio™ Advance, as well as the look and feel, improvements have been made to the tubing, tubing connector, and adhesive patch so that it can last longer. The two sets can be visibly distinguished from one another because the Extended™ infusion set has blue packaging and a blue cap.

No, the standard reservoir is labeled for use up to 3 days and must be changed every 3 days. We recommend using the Medtronic Extended™ infusion set and Extended™ reservoir together. The Extended™ reservoir is labeled for use up to 7 days and thus only needs to be changed when insulin runs out or when the infusion set is changed.

Watch this video for a full tutorial.
Compare infusion sets Infusion set support User guides and manuals Shop online

References

1. Chattaraj S, et al. The Medtronic extended-wear infusion set: Determining mechanisms of action. As presented at the 14th International Conference on Advanced Technologies & Treatments for Diabetes; June 2-5, 2021.
2. Chattaraj S, et al. Study of insulin stability impact on pump therapy: Test model development. Diabetes. 2020;69 (Supplement 1):1012-P
3. Zhang G, et al. Assessment of adhesive patches for an extended-wear infusion set. Diabetes. 2020;69 (Supplement 1):986-P
4. Chattaraj S, et al. 1167-P - CSII and Insulin: Does extending the wear duration of infusion sets save expensive insulin? 80th ADA International Conference, June 2020.
5. Medtronic Data on File. MiniMed™ Mio™ Advance US Pivotal Trials. 152 patients interviewed. 2020.
6. MRM 17430 MiniMed™ Mio Advance claims from Human Factors Testing. Medtronic data on file.
7. IFU & User Guide Comparison. Medtronic data on File.

* vs the 3-days infusion set MiniMed™ Quick-set™
† Taking a bolus 15 – 20 minutes before a meal helps to keep blood sugar levels under control after eating.
‡ Refers to SmartGuard™ feature. Individual results may vary.

Important Safety Information

Medtronic Extended™ infusion set
The Extended™ Infusion Set is indicated for up to 7 days of wear for the subcutaneous infusion of insulin from an infusion pump. It is NOT indicated for intravenous (IV) infusion or the infusion of blood or blood products. Inaccurate medication delivery, infection and/or site irritation may result from improper insertion and maintenance of the infusion site. Before insertion, clean the insertion site with isopropyl alcohol. Remove the needle guard before inserting the infusion set. If using this infusion set for the first time, do the first set-up in the presence of your healthcare professional. Do not leave air in the infusion set. Prime completely. Check frequently to make sure the soft cannula remains firmly in place as you may not feel pain if it pulls out. The soft cannula must always be completely inserted to receive the full amount of medication. If the infusion site becomes inflamed, replace the set, and use a new site until the first site has healed. Replace the infusion set if the tape becomes loose, or if the soft cannula becomes fully or partially dislodged from the skin. Regularly replace the infusion set as indicated in the instructions for use, or per the insulin labeling, whichever duration is shorter. For more details, see https://www.medtronicdiabetes.com/important-safety-information.

Medtronic Extended™ reservoir
The Extended™ Reservoir is indicated for the subcutaneous infusion of insulin from compatible Medtronic insulin pumps and infusion sets. Refer to your Medtronic insulin pump user guide for a list of compatible insulins and infusion sets. The reservoir is contraindicated for the infusion of blood or blood products. Use for a maximum of 7 days, or according to the insulin labeling, whichever duration is shorter. For more details, see important safety information.

MiniMed™ 770G System With SmartGuard™ Technology
The MiniMed™ 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 770G System includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose values (SG) and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed™ 770G System consists of the following devices: MiniMed™ 770G Insulin Pump, the Guardian™ Link (3) Transmitter, the Guardian™ Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the AccuChek®Guide Test Strips. The system requires a prescription.

The Guardian™ Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ Sensor (3).

All therapy adjustments should be based on measurements obtained using the Accu-Chek® Guide Link blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.

WARNING: Do not use the SmartGuard™ Auto Mode for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in SmartGuard™ Auto Mode.

WARNING: Do not use the MiniMed™ 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 770G system.

Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safetyinformation#minimed-770g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library


MiniMed™ 780G system with SmartGuard™ technology with Guardian™ 4 sensor

The MiniMed™ 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons seven years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 780G system includes SmartGuard™ technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed™ 780G system consists of the following devices: MiniMed™ 780G insulin pump, the Guardian™ 4 transmitter, the Guardian™ 4 sensor, One-press serter, the Accu-Chek™ Guide Link blood glucose meter, and the Accu-Chek™ Guide test strips. The system requires a prescription from a healthcare professional.

The Guardian™ 4 sensor is intended for use with the MiniMed™ 780G system and the Guardian 4 transmitter to monitor glucose levels for the management of diabetes. The sensor is intended for single use and requires a prescription. The Guardian™ 4 sensor is indicated for up to seven days of continuous use.

The Guardian™ 4 sensor is not intended to be used directly to make therapy adjustments while the MiniMed™ 780G is operating in manual mode. All therapy adjustments in manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ 4 sensor. The Guardian™ 4 sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Do not use the Guardian™ 4 sensor in the abdomen or other body sites including the buttocks, due to unknown or different performance that could result in hypoglycemia or hyperglycemia.

WARNING: Do not use the SmartGuard™ feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard™ feature.

WARNING: Do not use the MiniMed™ 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 780G system.

WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard™ feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a BG meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.

Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women, persons with type 2 diabetes, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-780g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library